Four lesions in particular—TP53 inactivation, CDKN2A/B loss, NOTCH1 activation, and MYC dysregulation—consistently emerge as central hallmarks of RT pathogenesis, forming a genetic foundation upon which indolent CLL evolves into aggressive lymphoma [21,24]. The gene discussed is MYC; the disease is B-cell chronic lymphocytic leukemia.